nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.345	0.386	CbGbCtD
Moclobemide—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.287	0.321	CbGbCtD
Moclobemide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.262	0.293	CbGbCtD
Moclobemide—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.0484	CcSEcCtD
Moclobemide—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.0367	CcSEcCtD
Moclobemide—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.0343	CcSEcCtD
Moclobemide—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.0314	CcSEcCtD
Moclobemide—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.0308	CcSEcCtD
Moclobemide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.0295	CcSEcCtD
Moclobemide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0292	CcSEcCtD
Moclobemide—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.0291	CcSEcCtD
Moclobemide—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.0276	CcSEcCtD
Moclobemide—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.0271	CcSEcCtD
Moclobemide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0253	CcSEcCtD
Moclobemide—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.0244	CcSEcCtD
Moclobemide—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.024	CcSEcCtD
Moclobemide—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.0223	CcSEcCtD
Moclobemide—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0207	CcSEcCtD
Moclobemide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0207	CcSEcCtD
Moclobemide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0184	CcSEcCtD
Moclobemide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0178	CcSEcCtD
Moclobemide—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0177	CcSEcCtD
Moclobemide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0164	CcSEcCtD
Moclobemide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0163	CcSEcCtD
Moclobemide—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0163	CcSEcCtD
Moclobemide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0161	CcSEcCtD
Moclobemide—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0157	CcSEcCtD
Moclobemide—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0156	CcSEcCtD
Moclobemide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0154	CcSEcCtD
Moclobemide—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0153	CcSEcCtD
Moclobemide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.015	CcSEcCtD
Moclobemide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0143	CcSEcCtD
Moclobemide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0141	CcSEcCtD
Moclobemide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0141	CcSEcCtD
Moclobemide—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0141	CcSEcCtD
Moclobemide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.014	CcSEcCtD
Moclobemide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0138	CcSEcCtD
Moclobemide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0137	CcSEcCtD
Moclobemide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0131	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0123	CcSEcCtD
Moclobemide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0123	CcSEcCtD
Moclobemide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0122	CcSEcCtD
Moclobemide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0121	CcSEcCtD
Moclobemide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.012	CcSEcCtD
Moclobemide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0119	CcSEcCtD
Moclobemide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0118	CcSEcCtD
Moclobemide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0117	CcSEcCtD
Moclobemide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0116	CcSEcCtD
Moclobemide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0112	CcSEcCtD
Moclobemide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0111	CcSEcCtD
Moclobemide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0108	CcSEcCtD
Moclobemide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0107	CcSEcCtD
Moclobemide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00972	CcSEcCtD
Moclobemide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00959	CcSEcCtD
Moclobemide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000984	0.00927	CcSEcCtD
Moclobemide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000951	0.00896	CcSEcCtD
Moclobemide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.00862	CcSEcCtD
Moclobemide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000907	0.00855	CcSEcCtD
Moclobemide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000906	0.00854	CcSEcCtD
Moclobemide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.00849	CcSEcCtD
Moclobemide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000854	0.00805	CcSEcCtD
